UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002933
Receipt number R000003568
Scientific Title A multi-centre trial for the treatment of oral leukoplakia with the aid of chemopreventive agents
Date of disclosure of the study information 2009/12/23
Last modified on 2009/12/23 16:00:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multi-centre trial for the treatment of oral leukoplakia with the aid of chemopreventive agents

Acronym

Chemoprevention of oral leukoplakia

Scientific Title

A multi-centre trial for the treatment of oral leukoplakia with the aid of chemopreventive agents

Scientific Title:Acronym

Chemoprevention of oral leukoplakia

Region

Japan


Condition

Condition

Oral leukoplakia

Classification by specialty

Oral surgery Dental medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the utility of low-dose beta-carotene with vitamin C supplements for the treatment and against malignant transformation of oral leukoplakia among non-smokers

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Clinical remission

Key secondary outcomes

Likelihood of malignant transformation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

One year supplement of 5mg 2 times/day of beta-carotene and 250mg 2 times/day of vitamin C

Interventions/Control_2

One year supplement of 25mg 2 times/day of vitamin C

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Predominantly white lesion of oral mucosa clinically diagnosed as leukoplakia based on the WHO criteria and confirmed histologically
2) Both non-dysplastic and those with mild to moderate dysplasia histo-pathologically
3) Non-smokers or ex-smokers more than 3 months
4) Discontinuing to take any over the counter micronutrient supplements 4 weeks prior to entering the trial

Key exclusion criteria

1) Any other specific disorders that could appear as a white lesion such as frictional keratosis, hairly leukoplakia, leukoedema, oral lichen planus and erythroplakia
2) Severe dysplasia, carcinoma in situ or micro-invasive carcinoma
3) Current smokers
4) Having adverse medical problems
5) Pregnancy

Target sample size

46


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toru Nagao

Organization

Aichi-Gakuin University School of Dentistry

Division name

Department of Maxillofacial Surgery

Zip code


Address

2-11,Suemori-dori,Chikusa-ku, Nagoya 464-8651,Japan

TEL

052-759-2160

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hideo Fukano

Organization

Chemoprevention Study Group for Oral Leukoplakia

Division name

Department of Maxillofacial Surgery, Aichi-Gakuin University School of Dentistry

Zip code


Address

2-11,Suemori-dori,Chikusa-ku, Nagoya 464-8651,Japan

TEL

052-759-2160

Homepage URL


Email

hifu0125@dpc.aichi-gakuin.ac.jp


Sponsor or person

Institute

Department of Maxillofacial Surgery, Aichi-Gakuin University School of Dentistry

Institute

Department

Personal name



Funding Source

Organization

Great Britain Sasakawa Foundation, UK

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization

UK


Other related organizations

Co-sponsor

Department of Oral Medicine, WHO Collaborating Centre for Oral Cancer Precancer,King's College Dental Institute at Guy's,King's&St.Thomas' Hospitals London,UK

Name of secondary funder(s)

DSM Nutrition Japan


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛知学院大学歯学部附属病院(愛知県)


Other administrative information

Date of disclosure of the study information

2009 Year 12 Month 23 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The overall clinical response rate in the experimental arm (low dose of beta-carotene and vitamin C) was 17.4% and 4.3% in the placebo arm (P=0.346). During the follow-up period (median 60 months), two subjects in the experimental arm and three subjects in the control arm developed oral cancer. The relative risk for supplementing with beta-carotene and vitamin C was 0.77 (95%CI: 0.28-1.89) (P=0.580) by the Cox proportional hazards model. No untoward side effects have been noted.
The supplemental low dose of beta-carotene and vitamin C for oral leukoplakia among non-smokers were neither effective for clinical remission nor for protection against cancer development statistically.
(The Annual Conference of the British Association of Oral Surgeons ,December 2009, Birmingham,UK)

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2000 Year 12 Month 22 Day

Date of IRB


Anticipated trial start date

2001 Year 06 Month 01 Day

Last follow-up date

2009 Year 10 Month 01 Day

Date of closure to data entry

2009 Year 11 Month 01 Day

Date trial data considered complete

2009 Year 11 Month 01 Day

Date analysis concluded

2009 Year 11 Month 01 Day


Other

Other related information



Management information

Registered date

2009 Year 12 Month 23 Day

Last modified on

2009 Year 12 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003568